William Marth

William S.
Marth is President, Co-Chief Executive Officer & Director at Teva Spanish Holdco, Inc. since 2011.
He is President & Chief Executive Officer at RTP Operating LLC.
He is President, Chief Executive Officer & Director at National Resilience, Inc. since 2024.
He is Director at Heritage Pharmaceuticals, Inc. since 2018.
He is Director at Emcure Pharma UK Ltd. He is President at Gemin X Pharmaceuticals US, Inc. He is Managing Partner at North Ocean Ventures LLC since 2020.
Formerly, Mr. Marth was President & Chief Executive Officer at Teva Pharmaceutical Industries Ltd. from 2010 to 2012.
He was President & Chief Executive Officer at Curia Global, Inc. from 2017 to 2018.
He was President & Chief Executive Officer at Teva Pharmaceuticals USA, Inc. from 2005 to 2008.
He was President & Chief Executive Officer at Teva North America from 2008 to 2010.
He was President & CEO-North America & Europe at Heritage Pharma Holdings, Inc. from 2018 to 2020.
He was Chairman at Association for Accessible Medicines from 2008 to 2009.
He was Chairman at American Society of Health-System Pharmacists, Inc. He was Chairman at Sorrento Therapeutics, Inc. He was Independent Director at VJGJ, Inc. in 2021.
He was Director at the University of the Sciences in Philadelphia.
He was President & Director at Curia Massachusetts, Inc. He was Independent Director at Galmed Pharmaceuticals Ltd. He was President at Cephalon LLC.
Mr. Marth earned an MBA degree from Keller Graduate School of Management in 1989.